Search

Search bills, members, committees and pages...

Sign In

HANSJORG SAUER

PreviousNext

14 federal lobbying filings, 2023 to 2025.

HANSJORG SAUER is a registered lobbyist named on 14 federal lobbying filings, 2023 to 2025.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

1 they have filed under, by filings.

RegistrantFilingsReported
BIOTECHNOLOGY INNOVATION ORGANIZATION14—

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20254—$5.6M
20245—$8.5M
20235—$11.2M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
BUDBudget/Appropriations14
CPTCopyright/Patent/Trademark14
HCRHealth Issues14
HOMHomeland Security14
MEDMedical/Disease Research/Clinical Labs14
MMMMedicare/Medicaid14
SMBSmall Business14
TAXTaxation/Internal Revenue Code14
TRDTrade (domestic/foreign)14
AGRAgriculture12
ANIAnimals12
CHMChemicals/Chemical Industry12
ENGEnergy/Nuclear12
FOOFood Industry (safety, labeling, etc.)12
FUEFuel/Gas/Oil12

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1262Mikaela Naylon Give Kids a Chance Act4
H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…4
H.R. 1672Maintaining Investments in New Innovation Act4
H.R. 946ORPHAN Cures Act4
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.3
S. 1096Preserve Access to Affordable Generics and Biosimilars Act3
S. 1097Interagency Patent Coordination and Improvement Act of 20253
S. 527Prescription Pricing for the People Act of 20253
H.R. 3152Patent Eligibility Restoration Act of 20252
H.R. 3160PREVAIL Act2
H.R. 3493Global Fairness in Drug Pricing Act2
H.R. 3701Family Vaccine Protection Act2
H.R. 5256340B ACCESS Act2
S. 1041Affordable Prescriptions for Patients Act2
S. 1095Stop STALLING Act2
S. 1546Patent Eligibility Restoration Act of 20252
S. 1553PREVAIL Act2
S. 2082Nuclear REFUEL Act of 20252
S. 2276ETHIC Act2
S. 2658Medication Affordability and Patent Integrity Act2
S. 43Skinny Labels, Big Savings Act2
S. 526Pharmacy Benefit Manager Transparency Act of 20252
S. 705Innovation in Pediatric Drugs Act of 20252
S. 864HELP Copays Act2
S. 946MATE Improvement Act2

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2025 fourth_quarter$1.5MJan 20, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2025 third_quarter$1.4MOct 20, 2025
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2025 second_quarter$1.8MJul 21, 2025
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2025 first_quarter$890KApr 21, 2025
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2024 fourth_quarter$1.5MJan 21, 2025
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2024 third_quarter$1.7MOct 21, 2024
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2024 second_quarter$1.8MJul 22, 2024
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2024 first_quarter$1.8MApr 26, 2024
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2024 first_quarter$1.8MApr 23, 2024
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2023 fourth_quarter$2.2MJan 22, 2024
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2023 third_quarter$2.2MOct 20, 2023
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2023 second_quarter$2.2MSep 26, 2023
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2023 second_quarter$2.2MJul 20, 2023
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2023 first_quarter$2.4MApr 20, 2023